{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:59:58Z","timestamp":1771894798741,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"The Spanish Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["PID2020-119424RB-I00 \/ AEI \/ 10.13039\/501100011033"],"award-info":[{"award-number":["PID2020-119424RB-I00 \/ AEI \/ 10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012538","name":"The Swedish Cancer Foundation","doi-asserted-by":"crossref","award":["211447-Pj"],"award-info":[{"award-number":["211447-Pj"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Academic Infrastructure for Supercomputing in Sweden","award":["2018-05973"],"award-info":[{"award-number":["2018-05973"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aldehyde dehydrogenases (ALDHs) belong to a group of enzymes that play a vital role in various biological processes and cellular defence against aldehyde toxicity. The ALDH1A subfamily has largely been associated with elevated expression in cancer tissues, and in particular in cancer stem-like cells ALDH1A1 is a frequently expressed enzyme in stem cells and target for therapeutic intervention, however, other isoforms such as 1A2, 1A3, 2, 3A1 and 7A1 have drawn significant attention in the recent years due to their involvement in various pathophysiological conditions. The current study is aimed at therapeutic intervention of ALDH1A3 by developing new inhibitors with the aid of computer-assisted drug design approach. A mixed ligand- and structure-based virtual screening (VS) study employing 4 million compounds, was performed against the X-ray structure of ALDH1A3, supported by hierarchical and consensus docking employing 12 docking solutions, prediction of ADME properties, and binding free energy calculations, to identify new hit and selective compounds. One of the hit molecules (VS1) emerged as a new, and reversible inhibitor of ALDH1A3 from the biochemical screening and kinetic characterization. Molecular dynamics (MD) simulations further allowed us to distinguish between the protein\u2013ligand dynamics of the VS hits and retinoic acid (RA) bound to ALDH1A3, establishing a correlation with the observed experimental results, further comparing with the reported ALDH1A3 inhibitors. VS1 can be used as a good starting point for structure-based hit optimization and hit-to-lead identification. The outcomes of this work are expected to benefit researchers working on computational and rational design of new ALDH inhibitors against cancer and other pathophysiological disorders.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10822-025-00622-3","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:13:22Z","timestamp":1756660402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of a reversible ALDH1A3 inhibitor through a consensus docking-based virtual screening study"],"prefix":"10.1007","volume":"39","author":[{"given":"E.","family":"Batlle","sequence":"first","affiliation":[]},{"given":"R.","family":"Pequerul","sequence":"additional","affiliation":[]},{"given":"J.","family":"Farr\u00e9s","sequence":"additional","affiliation":[]},{"given":"L. A.","family":"Eriksson","sequence":"additional","affiliation":[]},{"given":"K.","family":"Pors","sequence":"additional","affiliation":[]},{"given":"V.","family":"Jha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"1","key":"622_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-2797(00)00211-8","volume":"129","author":"V Vasiliou","year":"2000","unstructured":"Vasiliou V, Pappa A, Petersen DR (2000) Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact 129(1):1\u201319. https:\/\/doi.org\/10.1016\/S0009-2797(00)00211-8","journal-title":"Chem Biol Interact"},{"issue":"2","key":"622_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1081\/DMR-120034001","volume":"36","author":"V Vasiliou","year":"2004","unstructured":"Vasiliou V, Pappa A, Estey T (2004) Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev 36(2):279\u2013299. https:\/\/doi.org\/10.1081\/DMR-120034001","journal-title":"Drug Metab Rev"},{"issue":"6","key":"622_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1517\/17425255.4.6.697","volume":"4","author":"SA Marchitti","year":"2008","unstructured":"Marchitti SA, Brocker C, Stagos D, Vasiliou V (2008) Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 4(6):697\u2013720. https:\/\/doi.org\/10.1517\/17425255.4.6.697","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000468794","volume":"46","author":"A Yoshida","year":"1992","unstructured":"Yoshida A, Hsu LC, Dav\u00e9 V (1992) Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme 46:239\u2013244. https:\/\/doi.org\/10.1159\/000468794","journal-title":"Enzyme"},{"issue":"8","key":"622_CR5","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1016\/S0021-9258(18)83802-9","volume":"264","author":"G Kurys","year":"1989","unstructured":"Kurys G, Ambroziak W, Pietruszkos R (1989) Human aldehyde dehydrogenase. J Biol Chem 264(8):4715\u20134721","journal-title":"J Biol Chem"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2012.06.025","volume":"59","author":"KS Fritz","year":"2013","unstructured":"Fritz KS, Petersen DR (2013) An overview of the chemistry and biology of reactive aldehydes. Free Radic Biol Med 59:85\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.06.025","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"622_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","volume":"11","author":"H Esterbauer","year":"1991","unstructured":"Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11(1):81\u2013128. https:\/\/doi.org\/10.1016\/0891-5849(91)90192-6","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"622_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cbi.2010.08.005","volume":"188","author":"H-S Yu","year":"2010","unstructured":"Yu H-S, Oyama T, Isse T, Kitagawa K, Pham T-T-P, Tanaka M, Kawamoto T (2010) Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chem Biol Interact 188(3):367\u2013375. https:\/\/doi.org\/10.1016\/j.cbi.2010.08.005","journal-title":"Chem Biol Interact"},{"issue":"1","key":"622_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0009-2797(95)03632-V","volume":"98","author":"CE Vaca","year":"1995","unstructured":"Vaca CE, Fang J-L, Schweda EKH (1995) Studies of the reaction of acetaldehyde with deoxynucleosides. Chem Biol Interact 98(1):51\u201367. https:\/\/doi.org\/10.1016\/0009-2797(95)03632-V","journal-title":"Chem Biol Interact"},{"issue":"21","key":"622_CR10","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1073\/pnas.1221478110","volume":"110","author":"P Mao","year":"2013","unstructured":"Mao P, Joshi K, Li J, Kim S-H, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, Wang M, Hu B, Cheng S-Y, Sobol RW, Nakano I (2013) Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci 110(21):8644\u20138649. https:\/\/doi.org\/10.1073\/pnas.1221478110","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"622_CR11","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1021\/acs.jmedchem.8b00930","volume":"61","author":"BC Huddle","year":"2018","unstructured":"Huddle BC, Grimley E, Buchman CD, Chtcherbinine M, Debnath B, Mehta P, Yang K, Morgan CA, Li S, Felton J, Sun D, Mehta G, Neamati N, Buckanovich RJ, Hurley TD, Larsen SD (2018) Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy. J Med Chem 61(19):8754\u20138773. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00930","journal-title":"J Med Chem"},{"issue":"5","key":"622_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ijc.30091","volume":"139","author":"J-J Duan","year":"2016","unstructured":"Duan J-J, Cai J, Guo Y-F, Bian X-W, Yu S-C (2016) ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int J Cancer 139(5):965\u2013975. https:\/\/doi.org\/10.1002\/ijc.30091","journal-title":"Int J Cancer"},{"issue":"1","key":"622_CR13","doi-asserted-by":"publisher","first-page":"35710","DOI":"10.1038\/srep35710","volume":"6","author":"A Moretti","year":"2016","unstructured":"Moretti A, Li J, Donini S, Sobol RW, Rizzi M, Garavaglia S (2016) Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD+ and retinoic acid. Sci Rep 6(1):35710. https:\/\/doi.org\/10.1038\/srep35710","journal-title":"Sci Rep"},{"key":"622_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108256","volume":"681","author":"R Pequerul","year":"2020","unstructured":"Pequerul R, Vera J, Gim\u00e9nez-Dejoz J, Crespo I, Coines J, Port\u00e9 S, Rovira C, Par\u00e9s X, Farr\u00e9s J (2020) Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis. Arch Biochem Biophys 681:108256. https:\/\/doi.org\/10.1016\/j.abb.2020.108256","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"622_CR15","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/sj.jid.5700753","volume":"127","author":"HB Everts","year":"2007","unstructured":"Everts HB, Sundberg JP, King LE, Ong DE (2007) Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle. J Invest Dermatol 127(7):1593\u20131604. https:\/\/doi.org\/10.1038\/sj.jid.5700753","journal-title":"J Invest Dermatol"},{"issue":"2","key":"622_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.0022-202X.2004.23223.x","volume":"123","author":"HB Everts","year":"2004","unstructured":"Everts HB, King LE, Sundberg JP, Ong DE (2004) Hair cycle-specific immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and Aldh1a3 indicate complex regulation. J Invest Dermatol 123(2):258\u2013263. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23223.x","journal-title":"J Invest Dermatol"},{"issue":"1","key":"622_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","volume":"202","author":"V Vasiliou","year":"2013","unstructured":"Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y (2013) Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact 202(1):2\u201310. https:\/\/doi.org\/10.1016\/j.cbi.2012.10.026","journal-title":"Chem Biol Interact"},{"issue":"3","key":"622_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V (2012) Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 64(3):520\u2013539. https:\/\/doi.org\/10.1124\/pr.111.005538","journal-title":"Pharmacol Rev"},{"issue":"12","key":"622_CR19","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.drudis.2014.09.009","volume":"19","author":"K Pors","year":"2014","unstructured":"Pors K, Moreb JS (2014) Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development? Drug Discov Today 19(12):1953\u20131963. https:\/\/doi.org\/10.1016\/j.drudis.2014.09.009","journal-title":"Drug Discov Today"},{"issue":"12","key":"622_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41419-018-1232-3","volume":"9","author":"G Li","year":"2018","unstructured":"Li G, Li Y, Liu X, Wang Z, Zhang C, Wu F, Jiang H, Zhang W, Bao Z, Wang Y, Cai J, Zhao L, Kahlert UD, Jiang T, Zhang W (2018) ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma. Cell Death Dis 9(12):1190. https:\/\/doi.org\/10.1038\/s41419-018-1232-3","journal-title":"Cell Death Dis"},{"issue":"1","key":"622_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molonc.2014.07.010","volume":"9","author":"P Marcato","year":"2015","unstructured":"Marcato P, Dean CA, Liu R-Z, Coyle KM, Bydoun M, Wallace M, Clements D, Turner C, Mathenge EG, Gujar SA, Giacomantonio CA, Mackey JR, Godbout R, Lee PWK (2015) Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling. Mol Oncol 9(1):17\u201331. https:\/\/doi.org\/10.1016\/j.molonc.2014.07.010","journal-title":"Mol Oncol"},{"issue":"9","key":"622_CR22","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Cheryl A (2011) Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10(9):1378\u20131384. https:\/\/doi.org\/10.4161\/cc.10.9.15486","journal-title":"Cell Cycle"},{"issue":"20","key":"622_CR23","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.4161\/cc.8.20.9761","volume":"8","author":"C Ginestier","year":"2009","unstructured":"Ginestier C, Julien W, Nathalie C, Florence M, Pascal F, Fran\u00e7ois B, Max S (2009) Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8(20):3297\u20133302. https:\/\/doi.org\/10.4161\/cc.8.20.9761","journal-title":"Cell Cycle"},{"issue":"5","key":"622_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1158\/1535-7163.MCT-19-0461","volume":"19","author":"D Yamashita","year":"2020","unstructured":"Yamashita D, Minata M, Ibrahim AN, Yamaguchi S, Coviello V, Bernstock JD, Harada S, Cerione RA, Tannous BA, La Motta C, Nakano I (2020) Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells. Mol Cancer Ther 19(5):1134\u20131147. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0461","journal-title":"Mol Cancer Ther"},{"key":"622_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cbi.2014.12.008","volume":"234","author":"CA Morgan","year":"2015","unstructured":"Morgan CA, Parajuli B, Buchman CD, Dria K, Hurley TD (2015) N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes. Chem Biol Interact 234:18\u201328. https:\/\/doi.org\/10.1016\/j.cbi.2014.12.008","journal-title":"Chem Biol Interact"},{"key":"622_CR26","doi-asserted-by":"crossref","unstructured":"Vallee, B. L. 1993 Daidzin\u202f: A Potent , Selective Inhibitor of Human Mitochondrial Aldehyde Dehydrogenase. 1993, 90 (February), 1247\u20131251.","DOI":"10.1073\/pnas.90.4.1247"},{"issue":"4","key":"622_CR27","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1021\/jm501900s","volume":"58","author":"CA Morgan","year":"2015","unstructured":"Morgan CA, Hurley TD (2015) Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. J Med Chem 58(4):1964\u20131975. https:\/\/doi.org\/10.1021\/jm501900s","journal-title":"J Med Chem"},{"issue":"11","key":"622_CR28","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","volume":"61","author":"S-M Yang","year":"2018","unstructured":"Yang S-M, Martinez NJ, Yasgar A, Danchik C, Johansson C, Wang Y, Baljinnyam B, Wang AQ, Xu X, Shah P, Cheff D, Wang XS, Roth J, Lal-Nag M, Dunford JE, Oppermann U, Vasiliou V, Simeonov A, Jadhav A, Maloney DJ (2018) Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity. J Med Chem 61(11):4883\u20134903. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00270","journal-title":"J Med Chem"},{"issue":"9","key":"622_CR29","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1021\/acs.jmedchem.9b01910","volume":"63","author":"L Quattrini","year":"2020","unstructured":"Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C (2020) Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells. J Med Chem 63(9):4603\u20134616. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01910","journal-title":"J Med Chem"},{"key":"622_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020356","author":"ELM Gelardi","year":"2021","unstructured":"Gelardi ELM, Colombo G, Picarazzi F, Ferraris DM, Mangione A, Petrarolo G, Aronica E, Rizzi M, Mori M, La Motta C, Garavaglia S (2021) A selective competitive inhibitor of aldehyde dehydrogenase 1A3 Hinders cancer cell growth invasiveness stemness In vitro. Cancers. https:\/\/doi.org\/10.3390\/cancers13020356","journal-title":"Cancers"},{"issue":"3","key":"622_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/cbdd.14176","volume":"101","author":"H Kamiyama","year":"2023","unstructured":"Kamiyama H, Miyano M, Ito D, Kimura T, Hagiwara K, Kogai H, Kaburagi Y, Kotake Y, Takase Y (2023) Identification of a novel ALDH1A3-selective inhibitor by a chemical probe with unrelated bioactivity: an approach to affinity-based drug target discovery. Chem Biol Drug Des 101(3):727\u2013739. https:\/\/doi.org\/10.1111\/cbdd.14176","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"622_CR32","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s42003-021-02949-7","volume":"4","author":"J Li","year":"2021","unstructured":"Li J, Garavaglia S, Ye Z, Moretti A, Belyaeva OV, Beiser A, Ibrahim M, Wilk A, McClellan S, Klyuyeva AV, Goggans KR, Kedishvili NY, Salter EA, Wierzbicki A, Migaud ME, Mullett SJ, Yates NA, Camacho CJ, Rizzi M, Sobol RW (2021) A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells. Commun Biol 4(1):1420. https:\/\/doi.org\/10.1038\/s42003-021-02949-7","journal-title":"Commun Biol"},{"issue":"5","key":"622_CR33","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1021\/acs.jmedchem.1c01367","volume":"65","author":"AIM Ibrahim","year":"2022","unstructured":"Ibrahim AIM, Batlle E, Sneha S, Jim\u00e9nez R, Pequerul R, Par\u00e9s X, R\u00fcngeler T, Jha V, Tuccinardi T, Sadiq M, Frame F, Maitland NJ, Farr\u00e9s J, Pors K (2022) Expansion of the 4-(diethylamino)benzaldehyde scaffold to explore the impact on aldehyde dehydrogenase activity and antiproliferative activity in prostate cancer. J Med Chem 65(5):3833\u20133848. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01367","journal-title":"J Med Chem"},{"issue":"12","key":"622_CR34","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1039\/D4MD00522H","volume":"15","author":"K Wang","year":"2024","unstructured":"Wang K, Huang Y, Wang Y, You Q, Wang L (2024) Recent advances from computer-aided drug design to artificial intelligence drug design. RSC Med Chem 15(12):3978\u20134000. https:\/\/doi.org\/10.1039\/D4MD00522H","journal-title":"RSC Med Chem"},{"issue":"19","key":"622_CR35","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1080\/07391102.2022.2141895","volume":"41","author":"B Sharma","year":"2023","unstructured":"Sharma B, Dhananjay B, Grigory V (2023) An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders. J Biomol Struct Dyn 41(19):9424\u20139436. https:\/\/doi.org\/10.1080\/07391102.2022.2141895","journal-title":"J Biomol Struct Dyn"},{"issue":"12","key":"622_CR36","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1007\/s00894-013-2044-0","volume":"19","author":"B Kamaraj","year":"2013","unstructured":"Kamaraj B, Rajendran V, Sethumadhavan R, Purohit R (2013) In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. J Mol Model 19(12):5587\u20135599. https:\/\/doi.org\/10.1007\/s00894-013-2044-0","journal-title":"J Mol Model"},{"key":"622_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/1568026614666140929124445","author":"E Lionta","year":"2014","unstructured":"Lionta E, Spyrou G, Vassilatis DK, Cournia Z (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem. https:\/\/doi.org\/10.2174\/1568026614666140929124445","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"622_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/07391102.2013.770373","volume":"32","author":"A Kumar","year":"2014","unstructured":"Kumar A, Vidya R, Rao S, Purohit R (2014) Relationship between a point mutation S97C in CK1\u03b4 protein and its affect on ATP-binding affinity. J Biomol Struct Dyn 32(3):394\u2013405. https:\/\/doi.org\/10.1080\/07391102.2013.770373","journal-title":"J Biomol Struct Dyn"},{"issue":"7958","key":"622_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov AV, Katritch V (2023) Computational approaches streamlining drug discovery. Nature 616(7958):673\u2013685. https:\/\/doi.org\/10.1038\/s41586-023-05905-z","journal-title":"Nature"},{"key":"622_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106324","volume":"181","author":"D Vemula","year":"2023","unstructured":"Vemula D, Jayasurya P, Sushmitha V, Kumar YN, Bhandari V (2023) CADD, AI and ML in drug discovery: a comprehensive review. Eur J Pharm Sci 181:106324. https:\/\/doi.org\/10.1016\/j.ejps.2022.106324","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"622_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66(1):334\u2013395. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"issue":"1","key":"622_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"622_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143437","author":"V Muralikrishnan","year":"2022","unstructured":"Muralikrishnan V, Fang F, Given TC, Podicheti R, Chtcherbinine M, Metcalfe TX, Sriramkumar S, O\u2019Hagan HM, Hurley TD, Nephew KP (2022) A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14143437","journal-title":"Cancers (Basel)"},{"issue":"3","key":"622_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1021\/acschembio.7b00685","volume":"13","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhu J-Y, Hong KH, Mikles DC, Georg GI, Goldstein AS, Amory JK, Sch\u00f6nbrunn E (2018) Structural basis of ALDH1A2 inhibition by irreversible and reversible small molecule inhibitors. ACS Chem Biol 13(3):582\u2013590. https:\/\/doi.org\/10.1021\/acschembio.7b00685","journal-title":"ACS Chem Biol"},{"issue":"2","key":"622_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/jm401508p","volume":"57","author":"B Parajuli","year":"2014","unstructured":"Parajuli B, Fishel ML, Hurley TD (2014) Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. J Med Chem 57(2):449\u2013461. https:\/\/doi.org\/10.1021\/jm401508p","journal-title":"J Med Chem"},{"issue":"3","key":"622_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1021\/cb500977q","volume":"10","author":"M Luo","year":"2015","unstructured":"Luo M, Gates KS, Henzl MT, Tanner JJ (2015) Diethylaminobenzaldehyde is a covalent, irreversible inactivator of ALDH7A1. ACS Chem Biol 10(3):693\u2013697. https:\/\/doi.org\/10.1021\/cb500977q","journal-title":"ACS Chem Biol"},{"issue":"3","key":"622_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"622_CR48","unstructured":"Schr\u00f6dinger Release 2023\u20132: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2023."},{"key":"622_CR49","unstructured":"Schr\u00f6dinger Release 2023\u20132: Prime, Schr\u00f6dinger, LLC, New York, NY, 2023."},{"issue":"2","key":"622_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical Pka predictions. J Chem Theory Comput 7(2):525\u2013537. https:\/\/doi.org\/10.1021\/ct100578z","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"622_CR51","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R, Friesner RA, Harder ED (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17(7):4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"622_CR52","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PCD Hawkins","year":"2010","unstructured":"Hawkins PCD, Skillman AG, Warren GL, Ellingson BA, Stahl MT (2010) Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and cambridge structural database. J Chem Inf Model 50(4):572\u2013584. https:\/\/doi.org\/10.1021\/ci100031x","journal-title":"J Chem Inf Model"},{"issue":"1","key":"622_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PCD Hawkins","year":"2007","unstructured":"Hawkins PCD, Skillman AG, Nicholls A (2007) Comparison of shape-matching and docking as virtual screening tools. J Med Chem 50(1):74\u201382. https:\/\/doi.org\/10.1021\/jm0603365","journal-title":"J Med Chem"},{"issue":"sup2","key":"622_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14756366.2016.1193736","volume":"31","author":"G Poli","year":"2016","unstructured":"Poli G, Martinelli A, Tuccinardi T (2016) Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies. J Enzyme Inhib Med Chem 31(sup2):167\u2013173. https:\/\/doi.org\/10.1080\/14756366.2016.1193736","journal-title":"J Enzyme Inhib Med Chem"},{"key":"622_CR55","doi-asserted-by":"publisher","DOI":"10.1021\/ci500424n","author":"T Tuccinardi","year":"2014","unstructured":"Tuccinardi T, Poli G, Romboli V, Giordano A, Martinelli A (2014) Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci500424n","journal-title":"J Chem Inf Model"},{"issue":"16","key":"622_CR56","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"2","key":"622_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"15","key":"622_CR58","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC (2015) DOCK 6: impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156. https:\/\/doi.org\/10.1002\/jcc.23905","journal-title":"J Comput Chem"},{"issue":"4","key":"622_CR59","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/ci7001236","volume":"47","author":"S Tietze","year":"2007","unstructured":"Tietze S, Apostolakis J (2007) Glamdock: development and validation of a new docking tool on several thousand protein\u2212ligand complexes. J Chem Inf Model 47(4):1657\u20131672. https:\/\/doi.org\/10.1021\/ci7001236","journal-title":"J Chem Inf Model"},{"issue":"4","key":"622_CR60","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein-ligand docking using GOLD. Proteins Struct Funct Genet 52(4):609\u2013623. https:\/\/doi.org\/10.1002\/prot.10465","journal-title":"Proteins Struct Funct Genet"},{"key":"622_CR61","doi-asserted-by":"publisher","unstructured":"Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide 2004 A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 47 (7): 1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430.","DOI":"10.1021\/jm0306430"},{"key":"622_CR62","doi-asserted-by":"publisher","unstructured":"Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye, L. L.; Pollard, W. T.; Banks, J. L. 2004 Glide: A New Approach for Rapid, Accurate Docking and Scoring. Enrichment Factors in Database Screening. J. Med. Chem. 47(7): 1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s.","DOI":"10.1021\/jm030644s"},{"issue":"21","key":"622_CR63","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49(21):6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"issue":"1","key":"622_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb O, St\u00fctzle T, Exner TE (2009) Empirical scoring functions for advanced protein\u2212ligand docking with plants. J Chem Inf Model 49(1):84\u201396. https:\/\/doi.org\/10.1021\/ci800298z","journal-title":"J Chem Inf Model"},{"issue":"4","key":"622_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003571","volume":"10","author":"S Ruiz-Carmona","year":"2014","unstructured":"Ruiz-Carmona S, Alvarez-Garcia D, Foloppe N, Garmendia-Doval AB, Juhos S, Schmidtke P, Barril X, Hubbard RE, Morley SD (2014) RDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput Biol 10(4):e1003571. https:\/\/doi.org\/10.1371\/journal.pcbi.1003571","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"622_CR66","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1021\/ja993663t","volume":"122","author":"EM Duffy","year":"2000","unstructured":"Duffy EM, Jorgensen WL (2000) Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water. J Am Chem Soc 122(12):2878\u20132888. https:\/\/doi.org\/10.1021\/ja993663t","journal-title":"J Am Chem Soc"},{"key":"622_CR67","doi-asserted-by":"publisher","unstructured":"Bowers, K. J.; Chow, D. E.; Xu, H.; Dror, R. O.; Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D.; Salmon, J. K.; Shan, Y.; Shaw, D. E. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. In SC \u201906: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing; 2006; p 43. https:\/\/doi.org\/10.1109\/SC.2006.54.","DOI":"10.1109\/SC.2006.54"},{"issue":"4","key":"622_CR68","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","volume":"97","author":"GJ Martyna","year":"1992","unstructured":"Martyna GJ, Klein ML, Tuckerman M (1992) Nos\u00e9-Hoover chains: the canonical ensemble via continuous dynamics. J Chem Phys 97(4):2635\u20132643. https:\/\/doi.org\/10.1063\/1.463940","journal-title":"J Chem Phys"},{"issue":"5","key":"622_CR69","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1103\/PhysRevB.44.2358","volume":"44","author":"RM Wentzcovitch","year":"1991","unstructured":"Wentzcovitch RM (1991) Invariant molecular-dynamics approach to structural phase transitions. Phys Rev B 44(5):2358\u20132361. https:\/\/doi.org\/10.1103\/PhysRevB.44.2358","journal-title":"Phys Rev B"},{"key":"622_CR70","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1063\/1.447334","volume":"81","author":"S Nos\u00e9","year":"1984","unstructured":"Nos\u00e9 S (1984) A unified formulation of the constant temperature molecular dynamics methods. J Chem Phys 81:511\u2013519. https:\/\/doi.org\/10.1063\/1.447334","journal-title":"J Chem Phys"},{"issue":"1","key":"622_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspect Drug Discov Des 18(1):113\u2013135. https:\/\/doi.org\/10.1023\/A:1008763014207","journal-title":"Perspect Drug Discov Des"},{"issue":"10","key":"622_CR72","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li J, Abel R, Zhu K, Cao Y, Zhao S, Friesner RA (2011) The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins Struct Funct Bioinform 79(10):2794\u20132812. https:\/\/doi.org\/10.1002\/prot.23106","journal-title":"Proteins Struct Funct Bioinform"},{"key":"622_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1773314","author":"V Jha","year":"2020","unstructured":"Jha V, Galati S, Volpi V, Ciccone L, Minutolo F, Rizzolio F, Granchi C, Poli G, Tuccinardi T (2020) Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1773314","journal-title":"J Biomol Struct Dyn"},{"key":"622_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010078","author":"V Jha","year":"2021","unstructured":"Jha V, Biagi M, Spinelli V, Di Stefano M, Macchia M, Minutolo F, Granchi C, Poli G, Tuccinardi T (2021) Discovery of monoacylglycerol lipase (MAGL) inhibitors based on a pharmacophore-guided virtual screening study. Molecules. https:\/\/doi.org\/10.3390\/molecules26010078","journal-title":"Molecules"},{"issue":"7","key":"622_CR75","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","volume":"14","author":"MJ Waring","year":"2015","unstructured":"Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Weir A (2015) An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14(7):475\u2013486. https:\/\/doi.org\/10.1038\/nrd4609","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"622_CR76","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/ar400103r","volume":"46","author":"A Priimagi","year":"2013","unstructured":"Priimagi A, Cavallo G, Metrangolo P, Resnati G (2013) The halogen bond in the design of functional supramolecular materials: recent advances. Acc Chem Res 46(11):2686\u20132695. https:\/\/doi.org\/10.1021\/ar400103r","journal-title":"Acc Chem Res"},{"issue":"5","key":"622_CR77","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/acsmedchemlett.9b00686","volume":"11","author":"L Quattrini","year":"2020","unstructured":"Quattrini L, Gelardi ELM, Petrarolo G, Colombo G, Ferraris DM, Picarazzi F, Rizzi M, Garavaglia S, La Motta C (2020) Progress in the field of aldehyde dehydrogenase inhibitors: novel Imidazo[1,2-a]pyridines against the 1A family. ACS Med Chem Lett 11(5):963\u2013970. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00686","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"622_CR78","doi-asserted-by":"publisher","first-page":"2166035","DOI":"10.1080\/14756366.2023.2166035","volume":"38","author":"J-J Duan","year":"2023","unstructured":"Duan J-J, Jiao C, Lei G, Yu S-C (2023) ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers. J Enzyme Inhib Med Chem 38(1):2166035. https:\/\/doi.org\/10.1080\/14756366.2023.2166035","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00622-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:22Z","timestamp":1762451782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00622-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"72"}}